Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum

Behavioural Processes

Volumn 71, Issue 2-3, 2006, Pages 258-267

  Body, S ^a   Asgari, K ^a   Cheung, T H C ^a   Bezzina, G ^a   Fone, K F C ^a   Glennon, J C ^b   Bradshaw, C M ^a   Szabadi, E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

5 HT 2 receptors; Corpus striatum; DOI; Free operant psychophysical procedure; MDL 100907; RS 102221; Temporal differentiation

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST;

BEHAVIOR; PERCEPTION; RODENT; TIME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DATA ANALYSIS; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; INSTRUMENTAL CONDITIONING; NONHUMAN; PSYCHOPHYSICS; RAT; RECEPTOR SENSITIVITY; TIME PERCEPTION;

AMPHETAMINES; ANIMALS; CONDITIONING, OPERANT; CORPUS STRIATUM; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LOGISTIC MODELS; MICROINJECTIONS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN AGONISTS; TIME PERCEPTION;

ANIMALIA;

EID: 31544462054     PISSN: 03766357     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beproc.2005.10.004     Document Type: Article

References (62)

1. A.S.A. Al-Ruwaitea, S.S.A. Al-Zahrani, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi 5-Hydroxytryptamine and interval timing C.M. Bradshaw E. Szabadi Time and Behaviour: Psychological and Neurobehavioural Analyses 1997 Elsevier Amsterdam
2. S.S.A. Al-Zahrani, M.-Y. Ho, D.N. Velazquez-Martinez, M. Lopez-Cabrera, C.M. Bradshaw, and E. Szabadi Effect of the destruction of the 5-hydroxytryptaminergic pathways on behavioural timing and 'switching' in a free-operant psychophysical procedure Psychopharmcology 127 1996 346 352
3. 3 receptors Behav. Pharmacol. 16 2005 43 51
4. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
5. 2A/2C agonism J. Pharmacol. Exp. Ther. 310 2004 687 694
6. C. Bishop, and P.D. Walker Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats Neuroscience 121 2003 649 657
7. L.A. Bizo, and K.G. White Pacemaker rate and the behavioral theory of timing J. Exp. Psychol. (Anim. Behav. Proc.) 20 1994 308 321
8. L.A. Bizo, and K.G. White The behavioral theory of timing: Reinforcer rate determines pacemaker rate J. Exp. Anal. Behav. 61 1994 19 33
9. S. Body, K. Asgari, J.F. Rickard, Z. Zhang, K.C.F. Fone, C.M. Bradshaw, and E. Szabadi Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour Psychopharmacology 181 2005 289 298
10. S. Body, T.-J. Chiang, S. Mobini, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure Psychopharmacology 158 2001 305 313
11. S. Body, T.-J. Chiang, S. Mobini, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion Pharmacol. Biochem. Behav. 71 2002 787 793
12. 2 receptor agonist, DOI (2,5-dimethoxy-4- iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule Behav. Pharmacol. 14 2003 599 607
13. 2A receptors Psychopharmacology 176 2004 154 165
14. S. Body, S. Kheramin, S. Mobini, M.-Y. Ho, D.N. Velazquez-Martinez, C.M. Bradshaw, and E. Szabadi Antagonism by WAY100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT depleted rats Behav. Pharmacol. 13 2002 514 603
15. 2C receptor antagonist Neuropharmacology 36 1997 621 629
16. 2A receptors in afferents of the rat striatum Synapse 39 2001 297 304
17. 2A receptor mRNA in human brain Brain Res. 676 1995 157 168
18. A.C. Catania, and G.S. Reynolds A quantitative analysis of the responding maintained by interval schedules of reinforcement J. Exp. Anal. Behav. 11 1968 327 383
19. T.-J. Chiang, A.S.A. Al-Ruwaitea, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi The influence of "switching" on the psychometric function in the free-operant psychophysical procedure Behav. Proc. 44 1998 197 209
20. T.-J. Chiang, A.S.A. Al-Ruwaitea, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi Effect of central 5-hydroxytryptamine depletion on performance in the free-operant psychophysical procedure: facilitation of switching, but no effect on temporal differentiation of responding Psychopharmacology 143 1999 167 173
21. T.-J. Chiang, A.S.A. Al-Ruwaitea, S. Mobini, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi Effects of d-amphetamine on performance on two operant timing schedules Psychopharmacology 150 2000 170 184
22. T.-J. Chiang, A.S.A. Al-Ruwaitea, S. Mobini, M.-Y. Ho, C.M. Bradshaw, and E. Szabadi Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules Psychopharmacology 151 2000 379 391
23. 2A receptor in the central nervous system of adult rat J. Comp. Neurol. 409 1999 187 209
24. P. De Deurwaerdere, and U. Spampinato Role of serotonin (2A) and serotonin (2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation J. Neurochem. 73 1999 1033 1042
25. A.M. Ferrandez, L. Hugueville, S. Lehericy, J.B. Poline, C. Marsault, and V. Pouthas Basal ganglia and supplementary motor area subtend duration perception: an fMRI study Neuroimage 19 2003 1532 1544
26. 2C receptors in nucleus accumbens regulate expression of the hypolocomotive and discriminative stimulus effects of cocaine Pharmacol. Biochem. Behav. 71 2002 745 756
27. J. Gibbon, C. Malpani, C.L. Dale, and C.R. Gallistel Toward a neurobiology of temporal cognition: advances and challenges Curr. Opin. Neurobiol. 7 1997 170 184
28. 2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken Mol. Brain Res. 54 1998 199 211
29. D.L. Harrington, K.Y. Haaland, and N. Hermanowicz Temporal processing in the basal ganglia Neuropsychology 12 1998 3 12
30. S.C. Hinton, and W.H. Meck How time flies: functional and neural mechanisms of interval timing C.M. Bradshaw E. Szabadi Time and Behaviour: Psychological and Neurobehavioural Analyses 1997 Elsevier Amsterdam
31. S.C. Hinton, and W.H. Meck Frontal-striatal circuitry activated by human peak-interval timing in the supra-seconds range Cog. Brain Res. 21 2004 171 182
32. M.-Y. Ho, D.N. Velazquez-Martinez, C.M. Bradshaw, and E. Szabadi 5-Hydroxytryptamine and interval timing behaviour Pharmacol. Biochem. Behav. 71 2002 773 785
33. D. Hoyer, J.P. Hannon, and G.R. Martin Molecular, pharmacological and functional diversity of 5-HT receptors Pharmacol. Biochem. Behav. 71 2002 533 554
34. K. Ikemoto, A. Nishimura, N. Okado, M. Mikuni, K. Nishi, and I. Nagatsu Human midbrain dopamine neurons express serotonin2A receptor: an immunohistochemical demonstration. Brain Res. 853 2000 377 380
35. 2A antagonist with a favourable CNS safety profile J. Pharmacol. Exp. Ther. 277 1996 968 981
36. P. Killeen, and J.G. Fetterman A behavioral theory of timing Psychol. Rev. 95 1988 274 295
37. P. Killeen, J.G. Fetterman, and L.A. Bizo Time's causes C.M. Bradshaw E. Szabadi Time and Behaviour: Psychological and Neurobehavioural Analyses 1997 Elsevier Amsterdam
38. 2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task Brain Res. Bull. 54 2001 65 75
39. 2 receptors Curr. Drug. Targets: CNS Neurol. Dis. 3 2004 11 26
40. 2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum J. Neurosci. 74 2000 693 701
41. A. Machado, and P. Guilhardi Shifts in the psychometric function and their implications for models of timing J. Exp. Anal. Behav. 74 2000 25 54
42. 1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex Eur. J. Pharmacol. 367 1999 197 206
43. M.S. Matell, and W.H. Meck Cortico-striatal circuits and interval timing: coincidence detection of oscillatory processes Cog. Brain Res. 21 2004 139 170
44. M.S. Matell, W.H. Meck, and M.A.L. Nicolelis Interval timing and the encoding of signal durations by ensembles of cortical and striatal neurons Behav. Neurosci. 117 2003 760 773
45. 2C receptors J. Neurosci. 21 2001 7781 7787
46. W.H. Meck, and A.M. Benson Dissecting the brain's internal clock: how frontal-striatal circuitry keeps time and shifts attention Brain Cog. 48 2001 195 211
47. I. Nenadic, C. Gaser, H.-P. Volz, T. Rammsayer, F. Hager, and H. Sauer Processing of temporal information and the basal ganglia: new evidence from fMRI Exp. Brain Res. 148 2003 238 246
48. 2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group Neuroscience 111 2002 163 176
49. A.L. Odum, L.M. Lieving, and D.W. Schaal Effects of d-amphetamine in a temporal discrimination procedure: selective changes in timing or rate dependency? J. Exp. Anal. Behav. 78 2002 195 214
50. M.A. Pastor, B.L. Day, E. Macaluso, K.J. Friston, and R.S.J. Frackowiak The functional neuroanatomoy of temporal discrimination J. Neurosci. 24 2004 2585 2591
51. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 2nd ed. 1998 Academic Press New York
52. 2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex Brain Res. 888 2001 51 59
53. J.R. Platt Temporal differentiation and the psychophysics of time M.D. Zeiler P. Harzem Advances in the Analysis of Behaviour, Reinforcement and Organisation of Behaviour vol. 1 1979 Wiley Chichester
54. 2C receptors Mol. Brain Res. 23 1994 163 178
55. M. Richelle, and H. Lejeune Time in Animal Behaviour 1980 Pergamon Press Oxford
56. C.J. Schmidt, J.H. Kehne, and A.A. Carr MDL 100,907: a selective 5-HT(2A) receptor antagonist for the treatment of schizophrenia CNS Drug Rev. 3 1997 49 67
57. 2A receptors in the ventral pallidum Brain Res. 761 1997 97 104
58. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioural, electrophysiological and neurochemical studies J. Pharmacol. Exp. Ther. 266 1993 684 691
59. D.A. Stubbs Scaling of stimulus duration by pigeons J. Exp. Anal. Behav. 26 1976 15 25
60. D.A. Stubbs Temporal discrimination and a free-operant psychophysical procedure J. Exp. Anal. Behav. 33 1980 167 185
61. D.E. Wright, K.B. Seroogy, K.H. Lundgren, B.M. Davis, and L. Jennes Comparative localization of serotonin1A,1C and 2 receptor subtype mRNAs in rat brain J. Comp. Neurol. 351 1995 357 373
62. 2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission Brain Res. Bull. 51 2000 75 81